Skip to content

Arena Pharmaceuticals, Inc.

CIK 0001080709

← back to feed
Revenue (TTM)
$20K
−83.1% YoY FY Feb 2022
Net Income (TTM)
−$558.26M
−52.3% YoY FY Feb 2022
EPS Diluted (TTM)
−$9.28
−37.2% YoY FY Feb 2022
Gross Margin
-33,150.0%
FY Feb 2022
Operating Margin
-2,848,355.0%
FY Feb 2022
Net Margin
-2,791,310.0%
FY Feb 2022
Free Cash Flow (TTM)
$491.79M
FY Feb 2022
Cash
$224.57M
FY Feb 2022
Total Debt
—
FY Feb 2022
Shares Outstanding
61.66M sh
FY Feb 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings